NCT06877182 · ACTIVE NOT RECRUITING
Novel Neuroradiological Workflow for the Assisted DIAgnosis and Management of DEMentia with Artificial Intelligence
This trial is testing whether an AI-powered MRI analysis workflow can more accurately identify and track Alzheimer's disease and other dementias. Researchers are feeding brain MRI scans into machine learning models to see if AI can standardize and improve how radiologists interpret those images. The phase is unspecified, so this appears to be a diagnostic methods study rather than a traditional drug trial testing safety or effectiveness.
Eligibility criteria
Inclusion Criteria: * patients who perform brain magnetic resonance during the last 20 years Exclusion Criteria: -
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-03-19